Conferences
IBCN 2018: PPARɣ-Mediated Repression of TFAP2A Expression Identifies an Important Transcriptional Circuit in Basal-Squamous Bladder Cancer
October 12, 2018
IBCN 2018: Defining the Proteomic Landscape of Non – Muscle Invasive Bladder Cancer
October 12, 2018
IBCN 2018: MIBC Genomics in and Beyond TCGA and the PanCancerAtlas
October 12, 2018
IBCN 2018: Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer
October 12, 2018
IBCN 2018: Genomic and Transcriptomic Heterogeneity in Bladder Cancer - Impact on Clinical Decision Making?
October 12, 2018
IBCN 2018: Spatial and Temporal Heterogeneity in Bladder Cancer with Basal Phenotype
October 12, 2018
IBCN 2018: Mismatch Repair Deficiency in Upper Tract and Bladder Urothelial Carcinoma
October 12, 2018
Trust in Non-conventional Therapies by Cancer Patients Not Matched with Proper Awareness About Their Risks
October 11, 2018
NSAUA 2018: Artificial Intelligence in Urology: Alexa to Terminator, “Now You Shall Cut to Heal”
October 11, 2018
Janssen to Showcase Robust Oncology Portfolio at ESMO 2018 Congress
October 10, 2018
Bayer to Showcase Latest Oncology Research at ESMO 2018 Congress
October 9, 2018
Clovis Oncology to Highlight Results from Rucaparib TRITON Prostate Program at ESMO 2018 Congress
October 9, 2018
SIU 2018: Cardiovascular Disease and Cancer in Men
October 8, 2018
SIU 2018: Men’s Health: A Global Perspective
October 8, 2018